Email Updates

You are here

Home

9 SEPTEMBER 2022 VOLUME 24 ISSUE 36

Media Coverage

  • US May Expand Monkeypox Vaccine Eligibility to Men With HIV

    US officials are considering broadening recommendations for who gets vaccinated against monkeypox, possibly to include many men with HIV or those recently diagnosed with other sexually transmitted diseases. Driving the discussion is a study released Thursday showing that a higher-than-expected share of monkeypox infections are in people with other sexually transmitted infections. Dr. John T. Brooks, chief medical officer for the Centers for Disease Control and Prevention’s monkeypox outbreak response, said the report represents a “call to action.”

    September 8, 2022
    General
    Washington Post

  • Obamacare Can’t Require Coverage for Certain HIV Prevention Drugs, Federal Judge Rules

    A federal judge in Texas on Wednesday declared unconstitutional an Affordable Care Act requirement that insurers and employers offer plans that cover HIV-prevention drugs for free, saying it violates the religious freedom of a Christian-owned company. The ruling came as part of a broader decision that was a partial victory to Obamacare opponents who challenged the Affordable Care Act mandate for coverage of preventive services without charge.

    September 7, 2022
    PrEP
    CNN

  • Study Finds SA Street Sex Workers Have a High Chance of Being Infected With HIV

    One in every 18 street-based women sex workers of all ages in South Africa is estimated to be infected with HIV within a year. This is according to a consortium of investigators from six institutions, including Wits University, University of Cape Town, African Potential Consulting, Stellenbosch University, SA Medical Research Council and the National Institute for Communicable Diseases.

    September 7, 2022
    General
    City Press

  • At Long Last, We Might Have an HIV Vaccine

    HIV-1 is one of the fastest-mutating viruses ever studied. Over a dozen distinct subtypes exist, with countless specific versions of the virus varying from person to person. The extraordinary diversity of HIV-1 and rapid mutation rate makes vaccine development a challenge that researchers have failed to overcome for over three decades. However, a new vaccination strategy for HIV-1 induced a diverse arsenal of protective antibodies in monkeys.

    September 7, 2022
    HIV Vaccine
    Big Think

  • Government Can’t Mandate Coverage for Drugs That Prevent HIV Infections, Texas Federal Judge Rules

    A federal judge in Texas has ruled that a provision of the Affordable Care Act that mandates free coverage of certain drugs that prevent HIV infections violates the religious beliefs of a Christian-owned company. The ruling by U.S. District Judge Reed O’Connor came in response to a lawsuit filed by Jonathan Mitchell, a former Texas solicitor general and a conservative activist, on behalf of Braidwood Management Inc. and other self-described Christian employers and employees.

    September 7, 2022
    PrEP
    NBC News

  • US Regulator’s Decision on Vaginal Ring Denies Choice to Women Who Need HIV Prevention

    The Food and Drug Administration’s rejection of the dapivirine vaginal ring sets a dangerous precedent, Professor Erica Gollub and Raven Vaughan of Pace University argue in a commentary published in the journal AIDS Education and Prevention. “Absence of the dapivrine ring as an HIV risk reduction method for US women will result in a narrower set of choices for women, resulting in additional, preventable HIV infections,” they say.

    September 6, 2022
    PrEP
    aidsmap

  • Advocates Say Reforming HIV Laws Will Help Destigmatize Disease, Improve Public Health

    Advocates are again pushing Indiana legislators to reform the state’s laws concerning HIV. Experts say the laws worsen, not help, public health. There are several Indiana criminal laws that make penalties harsher if the offender knows they have HIV. An example: Indiana University sociologist Carrie Foote – who lives with HIV – said that if a person without the disease spits on someone else in Indiana, it’s a misdemeanor.

    September 6, 2022
    General
    WFYI Indianapolis

  • Gay Social and Sexual Norms Are Shifting in the PrEP Era

    While cost remains the biggest barrier to accessing PrEP for gay and bisexual men in Canada, they also felt pressure to take PrEP and have sex without condoms, with younger men tending to feel less anxious about HIV transmission. This reflects shifting social and sexual norms in the era of PrEP and U=U, according to recent qualitative research.

    September 5, 2022
    PrEP
    aidsmap

  • The Abortion Rights Movement Can Learn From the AIDS Activism of the 80s and 90s

    It was already chaos, and now, it was going to get worse. The US supreme court’s decision wasn’t exactly a surprise – everyone knew it was coming – but the rage in the room felt palpable. The language of the opinion had been taunting and cruel; the punishment from the court felt vindictive, personal. People were already dying for lack of access to healthcare; the ruling would push people in need even further to the margins. Now, the most vulnerable faced criminalization, harassment and even death, and for what?

    September 5, 2022
    General
    The Guardian

  • Monkeypox Infection Causing Acute Myocarditis – Case Report

    A recent case report published in the journal JACC Case Reports indicated that monkeypox infection might be associated with acute myocarditis or heart muscle inflammation. Monkeypox is a zoonotic virus that causes mild to moderate infection in humans, lasting 2 to 4 weeks. The most common symptoms are fever, skin rashes or lesions, and lymph node swelling. However, in some cases, infections can lead to severe medical complications. Currently, the case fatality ratio of monkeypox infection has been estimated to be 3-6 percent.

    September 5, 2022
    General
    News Medical

  • HIV Patients in Botswana Get Adequate Treatment but Not All of Them – One Group Is Slipping Through the Cracks

    HIV remains a major public health challenge globally. Around 38 million people are estimated to be living with the infection. Sub-Saharan Africa bears the brunt of the HIV epidemic. Close to two thirds of the HIV cases are in the region. But huge strides have been made in curbing the epidemic. One of the keys to this has been the introduction of antiretroviral therapy (ART). It's resulted in people with HIV living long, productive lives and reducing the risks of HIV transmission.

    September 5, 2022
    Treatment
    Modern Ghana

  • $20M in Federal Funds to Help Community Health Centers End HIV

    Some 64 community health centers will receive a total of more than $20 million in federal funding to expand their efforts to prevent, test for and treat HIV. The funds were awarded by the Health Resources and Services Administration (HRSA), a division of the Department of Health and Human Services (HHS). The funding supports the federal Ending the HIV Epidemic (EHE) initiative, which aims to reduce new HIV cases in the country by 75 percent by 2025 and by 90 percent by 2030.

    September 5, 2022
    General
    POZ Magazine

  • COVID-19 Nightmare Ends as Shagaan People Resume Annual Circumcision

    The Shangaan community in southeastern Lowveld has resumed the annual voluntary male circumcision and initiation with nearly 300 boys and men graduating at Chilonga Primary School in Chikombedzi over the weekend, following a near three-year hiatus caused by COVID-19.

    September 5, 2022
    Voluntary Medical Male Circumcision
    The Herald Zimbabwe

  • Protest in India Over HIV Drug Shortage Ends After 42 Days

    A protest by a group of HIV-positive people in New Delhi, demanding a regular supply of life-saving antiretroviral therapy drugs across the country, ended this week, after 42 days, as the government has reportedly resumed the interrupted supply of the drugs. Around 2.3 million people are infected with HIV in India. Since 2004, the government has been providing free antiviral therapy, known as ART, to HIV-positive people in India. The therapy stops replication of the virus, helping patients live longer and cutting the risk of transmission of the virus to others.

    September 3, 2022
    Treatment
    VOA

  • Study Raises Concerns About the Effectiveness of the Monkeypox Vaccine

    A new study is raising concerns about the effectiveness of the monkeypox vaccine being used in the United States and other parts of the world. The work, which has not yet been peer-reviewed, found that two doses of the vaccine induced relatively low levels of neutralizing antibodies against the monkeypox virus, and those antibodies had poor neutralizing capacity.

    September 2, 2022
    General
    STAT

  • PrEP Protection Against HIV is Complicated by Chronic HBV

    Persons with chronic hepatitis B who are at risk of contracting HIV can receive a double benefit from oral PrEP tenofovir-based formulations that protect from HIV and reduce hepatitis B virus (HPV) load; but can also suffer exacerbation of hepatitis when PrEP is discontinued. A recent review weighs the evidence for offering oral PrEP to this population, and finds best practices to favor benefit against risk.

    September 2, 2022
    PrEP
    Contagion Live

  • AIDS Memorial Quilt Heads to the South to “Change the Pattern”

    Sections of the AIDS Memorial Quilt are about to tour the Southern United States as part of in an initiative to honor Black and brown lives lost to HIV and to raise awareness of racial disparities that continue to fuel the epidemic. The Change the Pattern initiative will launch in Jackson, Mississippi, September 28 to October 4, with Quilt displays, educational forums, storytelling, advocacy, panel-making and other free programs.

    September 2, 2022
    General
    POZ Magazine

Published Research

Announcements